The molecular mechanisms underlying acute leptin and serotonin 2C receptor-induced hypophagia remain unclear. Here, we show that neuronal and pro-opiomelanocortin (Pomc)-specific loss of transient receptor potential cation 5 (TrpC5) subunits is sufficient to decrease energy expenditure and increase food intake resulting in elevated body weight. Deficiency of Trpc5 subunits in Pomc neurons is also sufficient to block the anorexigenic effects of leptin and serotonin 2C receptor (Ht2Cr) agonists. The loss of acute anorexigenic effects of these receptors is concomitant with a blunted electrophysiological response to both leptin and Ht2Cr agonists in arcuate Pomc neurons. We also demonstrate that the Ht2Cr agonist lorcaserin-induced improvements in glucose and insulin tolerance are blocked by TrpC5 deficiency in Pomc neurons. Together, our results link TrpC5 subunits in the brain with leptinand serotonin 2C receptor-dependent changes in neuronal activity, as well as energy balance, feeding behavior, and glucose metabolism.
In Brief Gao et al. show that TrpC5 subunits are essential for the negative energy balance associated with Pomc neuronal activation. TrpC5 subunits not only link the acute activities of leptin and serotonin receptors in Pomc neurons, but also modify direct effects on basal metabolism.TrpC5 subunits may provide an endogenous target to manipulate the activity of key neurons involved in the regulation of energy balance and glucose metabolism.
INTRODUCTION
Leptin receptors (LepRs) in the brain produce robust anti-obesity and anti-diabetic effects (Bjørbaek and Kahn, 2004; Coll et al., 2007; Elmquist et al., 1999; Flier, 2006; Friedman, 2004; Spiegelman and Flier, 2001) . Similarly, the neurotransmitter serotonin (5-hydroxytryptamine ) contributes to the regulation of feeding behavior, energy expenditure, and glucose homeostasis by acting via serotonin 2C receptors (Ht2Crs) within the CNS (Giorgetti and Tecott, 2004; Heisler et al., 2003) . The hypothalamic arcuate pro-opiomelanocortin (Pomc) neurons are vital in mediating both leptin's and serotonin's beneficial effects on metabolism (Balthasar et al., 2004; Berglund et al., 2012; Sohn et al., 2011) . Very recently, lorcaserin, an Ht2Cr-specific agonist, became the first US Food and Drug Administration (FDA)-approved weight-loss drug in the last 15 years independent of adverse cardiopulmonary effects. In order to better understand the effectiveness and safety of newly approved anti-obesity drugs, it is imperative to delineate cellular mechanisms underlying Ht2Cr and LepR activity in the brain.
There is an emerging role for TrpC channels in the regulation of energy homeostasis by leptin (Qiu et al., 2010) . Similarly, activation of Pomc neurons by Ht2Crs is mediated by a phospholipase C (PLC)-dependent activation of putative TrpC channels (Sohn et al., 2011) . Single-cell RT-PCR of arcuate Pomc neurons revealed that TrpC 1, 4, and 5 subunits predominate in murine Pomc neurons (Qiu et al., 2010) . However, TrpC1 alone may not be sufficient to form a functional ion channel (Str€ ubing et al., 2001) , suggesting that TrpC4 or TrpC5 may be a common target in Pomc neurons of these two potent anorexigenic signals, leptin and serotonin. In the current study, we studied the requirement of TrpC5 in the acute effects of leptin and serotonin to depolarize hypothalamic Pomc neurons. We also examined the requirement of TrpC5 subunits in the acute effects of leptin and serotonin on energy expenditure as well as glucose homeostasis.
RESULTS
Neuronal TrpC5 Subunits Are Required for Proper Energy Balance Disturbance of acute leptin or Ht2Cr signaling pathways in Pomc neurons is correlated with blunted acute anorexia by leptin and serotonin 2C receptor-agonists, as well as deficits in energy and glucose homeostasis (Hill et al., 2008; Xu et al., 2008 Xu et al., , 2010b . We hypothesized that leptin and Ht2Crs may acutely activate TrpC5 subunits within Pomc neurons, thus being required in vivo for the feeding effects of these receptors as well as regulating energy balance and glucose homeostasis. Figure 1A ). Subsequent breeding to ZP3-cre ( Figure 1B) , CamkIIa-cre, or Pomc-creER T2 mice generated mice deficient for TrpC5 in a cell-and tissue-type-dependent manner.
When fed a chow diet, neuron-(CamkIIa-cre, in which Cre recombinase is expressed widely in the forebrain and hindbrain; (E-I) Depictions of (E) unchanged oxygen consumption (VO 2 ), (F) unchanged carbon dioxide production (VCO 2 ), (G) increased respiratory exchange ratio (RER), (H) decreased heat production, and (I) unchanged ambulatory activity in male Pomc-cre::TrpC5 lox/Y mice.
(J) Male Pomc-cre::TrpC5 lox/Y mice exhibited increased food intake in the light cycle that resulted in hyperphagia over 24 hr.
(A-I) n = 8-15 per group; *p < 0.05. Error bars indicate SEM. Mice used in (E)-(I) were age-matched male littermates (8 weeks of age) and had comparable body weight and lean mass. Casanova et al., 2001) or Pomc-specific (Pomc-creER T2 -cre allows temporal control of cre recombinase activity in Pomc neurons; Berglund et al., 2013) deficiency of TrpC5 subunits resulted in an age-dependent increase in body weight ( Figures 1C and  1D ). The increased body weight was more pronounced in mice deficient for TrpC5 subunits in Pomc neurons alone ( Figure 1D ). Age-and weight-matched Pomc-creER T2 ::TrpC5 lox/Y males were hypometabolic, as demonstrated by significant decreases in energy expenditure ( Figures 1E-1H ) independent of altered activity levels ( Figure 1I ). Components of total energy expenditure include energy required for physical activities and basal metabolism. In particular, Pomc-creER T2 ::TrpC5 lox/Y mice exhibited decreased heat production ( Figure 1H ) suggestive of decreased metabolic rate. Pomc-creER T2 ::TrpC5 lox/Y mice also showed increased ad libitum food intake ( Figure 1J ). (Parton et al., 2007; Ramadori et al., 2010; Sohn et al., 2011) . Twenty-six Pomc neurons were from wildtype and 32 were in Pomc neurons deficient for TrpC5 subunits (Riccio et al., 2009) . Pomc neurons from wild-type mice (n = 26) had a resting membrane potential of À41.5 ± 1.3 mV, a mean input resistance of 1,260 ± 80 MU, and overshooting action potentials. When compared with values obtained from wild-type Pomc neurons, Pomc neurons deficient for TrpC5 exhibited a hyperpolarized mean resting membrane potential (À46.3 ± 0.9 mV; 1,085 ± 53 MU; n = 32; p < 0.05; Figure S1A ). Analogous results were obtained in Pomc neurons from Pomc-creER T2 versus Pomc-creER T2 ::TrpC5 lox/Y mice (resting membrane potential
Neuron-and
[RMP] = À44.3 ± 1.0 mV from wild-type Pomc neurons, n = 24; RMP = À48.0 ± 1.4 mV in Pomc neurons from PomccreER T2 ::Trpc5 lox/Y mice, n = 22; p < 0.05; Figure S1A ).
Similar to previous reports (Hill et al., 2008; Sohn et al., 2011) , Pomc neurons that express LepRs were targeted from PomchrGFP::LepR-cre-tdtomato (PLT) mice (Sohn et al., 2011; Sun et al., 2016; Williams et al., 2014) to test the acute cellular effects of leptin ( Figures 3A-3E ). Leptin (100 nM) depolarized 70.6% (12 out of 17) of wild-type Pomc neurons that express LepRs by 6.7 ± 0.5 mV (n = 12; Figures 3F and 3J; Table S1 ). We found one cell (5.9%) that was hyperpolarized by À10 mV, whereas the remaining four cells (23.5%) were not responsive to leptin (0.3 ± 0.3 mV, n = 4). Analysis of current-voltage relationships revealed that leptin decreased input resistance by 21.4% ± 3.0% (n = 12, from 1.2 ± 0.1 GU in control artificial cerebrospinal fluid (CSF) (ACSF) to 0.9 ± 0.1 GU in leptin) with a reversal potential of À26.0 ± 2.2 mV (n = 12) ( Figures 3G and 3H ). These results confirmed that leptin activates a non-selective cation conductance to depolarize Pomc neurons.
In contrast, leptin failed to depolarize any of 15 Pomc neurons that express LepRs from TrpC5 knockout (PLT5KO) sponsive to leptin (À0.1 ± 0.5 mV), whereas 1 cell (6.7%) was hyperpolarized by À9 mV. Analogous results were obtained in recordings from Pomc neurons selectively deficient for TrpC5 subunits (from Pomc-creER T2 ::TrpC5 mice; Figure S1B). These data suggest that TrpC5 subunits underlie the leptin-induced activation of a non-selective cation conductance resulting in the depolarization of Pomc neurons. Notably, the hyperpolarizing effects of leptin remained unchanged in Pomc neurons lacking TrpC5 subunits, and these effects were accompanied by decreased input resistance with a reversal potential close to equilibrium potential for potassium (E K ). Similar results were obtained in ventral premammillary nucleus (PMv) neurons that express leptin receptors (Supplemental Information; Figure S2 ). Thus, the null TrpC5 gene does not affect the functional expression of leptin receptors or other channels in our model.
After recordings, the sections were fixed in formalin to determine the location of recorded cells within the arcuate nucleus, as described previously (Sohn et al., 2011) . Because acute leptin responses show a distinct distribution pattern (Williams et al., 2010) , we targeted cells of similar region within the arcuate nucleus in both wild-type and TrpC5 knockout mice ( Figure 3K ).
The Acute mCPP-Induced Activation of Pomc Neurons Requires TrpC5 Subunits To test the acute cellular effects of Ht2Crs, we targeted Pomc neurons that do not express LepRs from PLT mice ( Figures  4A-4E ), as previously described (Sohn et al., 2011) . We confirmed that mCPP (4 mM) depolarized 55% (5 out of 9) of wild-type Pomc neurons that do not express LepRs by 6 ± 0.6 mV (n = 5; Figures 4F and 4J; Table S1 ). The remaining four cells (45%) were not responsive to mCPP (0.4 ± 0.2 mV; n = 4). Application of current steps revealed that mCPP decreases input resistance by 14.8% ± 4.8% (n = 5, from 1.5 ± 0.1 GU in control ACSF to 1.3 ± 0.1 GU in mCPP) with a reversal potential of À14 ± 4.8 mV (n = 5) (Figures 4G and  4H ). In contrast, mCPP failed to depolarize all Pomc neurons tested from Trpc5 knockout (PLT5KO) mice (0.1 ± 0.2 mV; n = 19; Figures 4I and 4J; Table S2 ). Similar to the acute leptin effects in the current study, we targeted cells in a similar region, and responses were mapped within the arcuate nucleus ( Figure 4K ).
The Lorcaserin-Induced Depolarization of Pomc Neurons Is Dependent upon TrpC5
We previously confirmed that the acute effects of mCPP on Pomc neurons were mediated by Ht2Crs (Berglund et al., 2013; Xu et al., 2010a) . Thus, the observed cellular effects of mCPP in the present study should depend upon Ht2Cr activation, and the lack of mCPP effects on Pomc neurons from the TrpC5 knockout mice indicate that Trpc5 is required for the acute activation of Pomc neurons by Ht2Crs.
However, to further examine this activity, we used lorcaserin (a specific Ht2Cr agonist recently approved for chronic weight management). Similar to results obtained with mCPP, lorcaserin (4 mM) depolarized 50% (6 out of 12) of wild-type Pomc neurons that do not express LepRs by 7.0 ± 0.7 mV (n = 6; Figures 5A and 5E; Table S1 ). The remaining six cells (50%) were not responsive to lorcaserin (0.3 ± 0.2 mV; n = 6). Application of current steps confirmed that lorcaserin decreased the input resistance by 25.6% ± 6.5% (n = 6; from 1.6 ± 0.1 GU in control ACSF to 1.2 ± 0.2 GU in lorcaserin) with a reversal potential of À13.1 ± 3.2 mV (n = 6) (Figures 5B and 5C [P2CT] mice; Supplemental Information; Figures S3 and S4; Table S3 ). As expected, lorcaserin failed to depolarize any of 12 Pomc neurons from TrpC5 knockout (PLT5KO) mice (Figures 5D and  5E ; Table S2 ). Eleven cells (91.7%) remained unresponsive to lorcaserin (0.4 ± 0.2 mV), whereas one cell (8.3%) was hyperpolarized by À8 mV. A summary of the location of targeted cells was mapped throughout the rostro-caudal extent of the arcuate nucleus ( Figure 5F ). Similar results were obtained in recordings from Pomc neurons selectively deficient for TrpC5 subunits (from Pomc-creER T2 ::TrpC5 mice; Figure S1C ; Table S4 ). These data confirm that TrpC5 subunits underlie the Ht2Cr-mediated activation of non-selective cation conductance and the depolarization of Pomc neuron membrane potential.
DISCUSSION
Neuronal or Pomc-specific TrpC5 deficiency resulted in a positive energy balance that contributed to excess weight gain. In addition to these physiological aberrations, global deficiency of TrpC5 as well as neuron-or Pomc-specific deficiency of TrpC5 alone abrogated the acute anorexigenic effects of both leptin and serotonin 2C receptor agonists. TrpC5 subunits were also required for the acute effects of lorcaserin to improve both glucose and insulin tolerance ( Figures S5 and S6) . On a cellular level, deficiency of TrpC5 subunits abrogates the acute effects of both leptin and serotonin 2C receptors to activate arcuate Pomc neurons. Together, these data demonstrate that TrpC5 subunits in arcuate Pomc neurons are important regulators of the pharmacological effects of both leptin and serotonin, and link critical molecular mechanisms with recently developed anti-obesity pharmacotherapeutics, such as lorcaserin. Multiple signaling cascades are activated in response to leptin receptor activation. In particular, phosphoinositol 3-kinase (PI3K) has been suggested to be required for the acute effects of leptin to stimulate Pomc neuronal activity via a putative activation of TrpC channels (Al-Qassab et al., 2009; Hill et al., 2008; Qiu et al., 2010) . Pharmacological inhibition of PI3K or targeted disruption of PI3K regulatory subunits in Pomc neurons alone blunted the suppression of feeding elicited by central leptin administration (Hill et al., 2008; Niswender et al., 2001 ). Moreover, mice deficient for PI3K catalytic activity exhibited central leptin resistance, increased adiposity, diet-induced obesity, and impaired glucose regulation (Al-Qassab et al., 2009; Hill et al., 2009 ). Importantly, these data are analogous to the observations detailed in the current study, supporting a role for the PI3K-TrpC5 pathway in the acute and chronic regulation of energy balance and glucose homeostasis.
It should be noted that a previous report demonstrated that global deficiency of TrpC5 subunits (Trpc5KO) fails to alter body weight (Riccio et al., 2009 ). However, numerous reports have demonstrated that global deficiency of various genes may result in compensatory adaptation (Luquet et al., 2007; Zeltser et al., 2012 ). In the current study, global TrpC5 deficiency resulted in improved glucose tolerance, whereas neuronal-or Pomc-specific loss of TrpC5 failed to alter basal glucose tolerance ( Figures S5 and S6 suggesting that Trpc5 subunits might ameliorate only specific components of the glucose-stimulated insulin response. Together, these data may suggest that inhibition of TrpC5 subunits in the periphery (possibly including TrpC5 subunits in adipose tissue) may improve glucose homeostasis; however, loss of TrpC5 subunits in Pomc neurons might impair energy balance and blunt targeted improvements in glucose metabolism. Although these data support possible mechanisms for improved energy balance and glucose metabolism via TrpC5 subunits, they also highlight the utility of cell-type targeted strategies to better identify roles for cellular signaling in energy balance and glucose metabolism. Another salient finding is that TrpC5 subunits in Pomc neurons alter basal metabolism and feeding behavior. Several reports using chemo-and opto-genetic strategies have highlighted the role of acutely modulating melanocortin cellular activity and resulting changes in feeding behavior and body weight (Aponte et al., 2011; Zhan et al., 2013) . However, identification of humoral signals linked to endogenous signaling cascades and channels that may acutely alter metabolism has remained undefined. Moreover, leptin's and serotonin's acute beneficial effects on metabolism are due at least in part to the acute activity of melanocortin neurons. In the current study we propose that activation of TrpC5 in arcuate Pomc neurons, as occurs in response to LepRs or Ht2Crs, represents a physiological cellular correlate to the light-and/or chemical-induced activation of channelrhodopsins/designer receptors exclusively activated by designer drugs (DREADDs) in Pomc neurons previously demonstrated to stimulate a negative energy balance (Aponte et al., 2011; Zhan et al., 2013) . Moreover, in addition to the pharmacological activity of leptin and Ht2Cr agonists, Trpc5 subunits contribute to a basal activity of melanocortin neurons that alters metabolic rate and feeding behavior.
Ht2Crs are known to regulate energy homeostasis and body weight. This regulatory impact is perhaps most notable due to the anti-obesity drug d-fenfluramine (d-Fen), which was identified to act via Ht2Cr (Vickers et al., 1999; Xu et al., 2008) . However, the cellular mechanism required for Ht2Cr-expressing neurons to mediate effects on energy homeostasis remains unclear. This is topical due to the recent approval by the FDA of the antiobesity drug, lorcaserin, which targets Ht2Cr for chronic weight management (Harlan et al., 2011; Martin et al., 2011) . Additionally, other Ht2Cr agonists are also being tested in humans to treat obesity, further reinforcing a need for mechanistic insights on how these compounds exert their effects (Rodgers et al., 2012) . Importantly, lorcaserin has also been associated with improvements of blood glucose levels in patients with type 2 diabetes (O'Neil et al., 2012) . Notably, in the current study, lorcaserin-induced acute improvements in glucose and insulin tolerance were observed and required TrpC5 subunits in Pomc neurons. This observation suggests potential weight-independent effects of lorcaserin and TrpC channels on blood glucose levels, which should be studied further.
It should be noted that, in addition to classic neuropeptides (Krashes et al., 2014; Liu et al., 2012; Pinto et al., 2004; Tong et al., 2008; Yang et al., 2011) . Arcuate Pomc neurons co-express glutamate (Collin et al., 2003; Kiss et al., 2005) , independent of NPY/AgRP and to a variable extent GABA (Hentges et al., 2004 (Hentges et al., , 2009 Horvath et al., 1997; Ovesjö et al., 2001; Wittmann et al., 2013; Yee et al., 2009) . It is currently unclear how TrpC5-dependent activation of arcuate Pomc neurons might differentiate between the release of either neurotransmitters or neuropeptides. Similarly, recent work suggests a sensory component of Pomc or NPY/AgRP neuronal activity that is likely independent of endogenous peptidergic signals (Betley et al., 2015; Chen et al., 2015) . Although currently unclear, involvement of pharmacological levels of leptin and serotonin 2C receptor agonists might act on these sensory cues influencing feeding behavior. Thus, the role of either neurotransmitters or neuropeptides in the Pomc-specific TrpC5-dependent regulation of metabolism warrants further investigation.
In summary, activation of arcuate Pomc neurons results in a negative energy balance (Aponte et al., 2011; Zhan et al., 2013) . Numerous peptides and neurotransmitters have been demonstrated to acutely stimulate the activity of arcuate Pomc neurons, including leptin and serotonin. Although several signaling mechanisms have been identified, the channel required for these activities has remained largely undefined. In the current study, we demonstrate that TrpC5 subunits are essential for the negative energy balance associated with Pomc neuronal activation. TrpC5 subunits not only link the acute activities of leptin and serotonin receptors in Pomc neurons, but also modify direct effects on basal metabolism. Similar to opto-and chemo-genetic strategies, TrpC5 subunits may provide an endogenous target to manipulate the activity of key neurons involved in the regulation of energy balance and glucose metabolism.
EXPERIMENTAL PROCEDURES Animals
Male (4-to 16-week-old) pathogen-free CamkIIa-cre, Pomc-creER T2 , PomchrGFP::LepR-cre::tdtomato (PLT), Pomc-hrGFP::Ht2Cr-cre::tdtomato (P2CT), TrpC5KO, and TrpC5 fl/y (described below) mice (Berglund et al., 2013; Parton et al., 2007; Ramadori et al., 2010; Riccio et al., 2009; Sohn et al., 2011; Sun et al., 2016) were used for all experiments. All mice were housed under standard laboratory conditions (12 hr on/off; lights on at 7:00 a.m.) and temperature-controlled environment with food and water available ad libitum. All experiments were performed in accordance with the guidelines established by the NIH Guide for the Care and Use of Laboratory Animals and approved by the University of Texas Institutional Animal Care and Use Committee.
Generation of a cre-Conditional TrpC5 Allele (TrpC5 fl/y )
The TrpC5-targeted clone obtained from EUCOMM was injected into blastocysts to obtain highly chimeric mice. These mice were then bred to obtain germline transmission of the targeted TrpC5 allele. The TrpC5 lox/Y mice were generated following flp-mediated removal of the neo cassette, leaving two loxP sequences flanking exons 5 of the TrpC5 gene. Deletion of exon 5 creates a frameshift mutation. 
Electrophysiology
Whole-cell patch-clamp recordings from Pomc-hrGFP neurons with or without leptin receptors were maintained in hypothalamic slice preparations, and data analysis was performed as previously described (Hill et al., 2008) . Briefly, 4-to 16-week-old male mice were anesthetized and transcardially perfused with a modified ice-cold artificial CSF (ACSF) (described below), in which an equiosmolar amount of sucrose was substituted for NaCl. The mice were then decapitated, and the entire brain was removed and immediately submerged in icecold, carbogen-saturated (95% O2 and 5% CO2) ACSF (126 mM NaCl, 2.8 mM KCl, 1.2 mM MgCl2, 2.5 mM CaCl2, 1.25 mM NaH2PO4, 26 mM NaHCO3, and 5 mM glucose). Coronal sections (250 mm) were cut with a Leica VT1000S Vibratome and then incubated in oxygenated ACSF at room temperature for at least 1 hr before recording. Slices were transferred to the recording chamber and allowed to equilibrate for 10-20 min before recording. The slices were bathed in oxygenated ACSF (32 C-34 C) at a flow rate of $2 mL/min.
The pipette solution for whole-cell recording was modified to include an intracellular dye (Alexa Fluor 594 or Alexa Fluor 350) for whole-cell recording: 120 mM K-gluconate, 10 mM KCl, 10 mM HEPES, 5 mM EGTA, 1 mM CaCl2, 1 mM MgCl2, 2 mM MgATP, and 0.03 mM Alexa Fluor 594 or Alexa Fluor 350 hydrazide dye (pH 7.3). Epifluorescence was briefly used to target fluorescent cells, at which time the light source was switched to infrared differential interference contrast imaging to obtain the whole-cell recording (Zeiss Axioskop FS2 Plus or Nikon FN1 equipped with a fixed stage and a QuantEM:512SC electron-multiplying charge-coupled device camera). Electrophysiological signals were recorded using an Axopatch 700B amplifier (Molecular Devices), low-pass-filtered at 2-5 kHz, and analyzed offline on a PC with pCLAMP programs (Molecular Devices). Recording electrodes had resistances of 2.5-5 MU when filled with the K-gluconate internal solution. Input resistance was assessed by measuring voltage deflection at the end of the response to a hyperpolarizing rectangular current pulse steps (500 ms of À10 to À50 pA).
Leptin (100 nM; provided by A.F. Parlow, through the National Hormone and Peptide Program), mCPP (4 mM; Sigma-Aldrich), and lorcaserin (4 mM; provided by Kathryn Cunningham) were added to the ACSF for specific experiments. Solutions containing leptin, mCPP, or lorcaserin were typically perfused for 2-4 min. A drug effect was required to be associated temporally with peptide application, and the response had to be stable within a few minutes. A neuron was considered depolarized or hyperpolarized if a change in membrane potential was at least 2 mV in amplitude.
Analyses of Leptin-, mCPP-, and Lorcaserin-Induced Hypophagia Leptin (5 mg/kg; provided by A.F. Parlow, through the National Hormone and Peptide Program), mCPP (3 mg/kg; Sigma-Aldrich), lorcaserin (1, 3, and 6 mg/kg; provided by Kathryn Cunningham), and vehicle (sterile saline) were administered i.p. in a counterbalanced manner to chow-fed 18 hr overnightfasted mice as previously described (Berglund et al., 2013; Williams et al., 2014; Xu et al., 2010b) . Food intake was measured hourly for 6 hr and then a single measurement at 24 hr.
Analyses of Lorcaserin-Induced Alterations in Glucose Tolerance Test and Insulin Tolerance Test
For glucose tolerance tests (GTTs), mice were intraperitoneally injected with 1.5 g/kg body weight of dextrose after an overnight fast. Mice were injected with lorcaserin (1.5 mg/kg) or vehicle 45 min prior to glucose injection. We drew blood samples at 0, 15, 30, 60, 90, and 120 min time points and measured glucose levels with a Bayer contour glucometer.
For insulin tolerance tests (ITTs), mice were fasted for 3 hr with water ad libitum. Mice were injected with lorcaserin (1.5 mg/kg) or vehicle 45 min prior to insulin injection. After measurement of basal levels of glucose, insulin (1.2 U/kg; Eli Lilly and Company) was administrated i.p. Blood glucose levels were monitored at given time points after insulin injection.
Statistics
Statistical analysis was carried out using GraphPad 5 (GraphPad) software. All data were evaluated using a two-tailed Student's t test or ANOVA where appropriate, with p < 0.05 being considered significant. In all instances, data are presented as mean ± SEM. Degrees of freedom (df) for t statistics are marked as t (df) .
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